Hyperthermic Intraperitoneal Chemoperfusion
Hyperthermic intraperitoneal chemoperfusion combines surgery and a novel form of chemotherapy that has been shown to significantly improve survival for peritoneal mesothelioma and other abdominal cancer patients. Unlike other forms of chemotherapy given as a pill or injection, HIPEC delivers the medicine by adding it to heated saline solution and pumping the mixture directly into the patient’s abdomen immediately after surgery. The heated cancer cells start to die when heated to around 104 degrees, while normal cells can survive up to 111 degrees, much like a fever fights off infection.
The typical HIPEC patient will have stage IV abdominal cancer such as peritoneal mesothelioma.